OP0200 ORAL DELIVERY OF DELTA-9-TETRAHYDROCANNABINOL PROVIDES SYMPTOM AND DISEASE MODIFICATION USING TWO MODELS OF KNEE OSTEOARTHRITIS
Rockel, J, Maglaviceanu, A, H Fetter Filippini, Poduch, E, Lewis-Bakker, M, Garcia, J, Leroux, T, Clarke, H, Bonin, R, Kotra, L, Kapoor, M
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
Oral Delivery Of Delta-9-Tetrahydrocannabinol Provides Symptom And Disease Modification In A Mouse Model Of Knee Osteoarthritis
Rockel, J.S., Maglaviceanu, A., Filippini, H. Fetter, Wasilewski, E., Lewis-Bakker, M.M., Gabrial, S., Rossomacha, E., Garcia, J., Leroux, T., Clarke, H., Bonin, R.P., Kotra, L.P., Kapoor, M.
Published in Osteoarthritis and cartilage (01.03.2023)
Published in Osteoarthritis and cartilage (01.03.2023)
Get full text
Journal Article
ORAL DELIVERY OF DELTA-9-TETRAHYDROCANNABINOL PROVIDES SYMPTOM AND DISEASE MODIFICATION IN A MOUSE MODEL OF KNEE OSTEOARTHRITIS
Rockel, J.S., Filippini, H. Fetter, Wasilewski, E., Lewis-Bakker, M.M., Gabrial, S., Rossomacha, E., Leroux, T., Clarke, H., Bonin, R.P., Kotra, L.P., Kapoor, M.
Published in Osteoarthritis and cartilage (01.04.2022)
Published in Osteoarthritis and cartilage (01.04.2022)
Get full text
Journal Article